The purpose of this study is to capture the real-world experience of CD patients treated with ustekinumab as part of their clinical care in a variety of care settings from large teaching/research centres to smaller district hospitals.
Inclusion Criteria:
Exclusion Criteria:
Bristol, Bristol BS2 8HW, United Kingdom
Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease
A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China
Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)